Skip Ribbon Commands
Skip to main content

Ambulatory Care: Optimizing your patients' journey

​Angio-Seal™ vascular closure device and FemoSeal™ vascular closure system achieve faster hemostasis than manual compression.1

With an efficient hemostasis, you may ensure the safety of your patients by reducing post-procedure bleeding complications.2

1Cox T et al. Surg Technol Int. 2015 Nov; 27:32-44.

2Marso SP et al. JAMA. 2010; 303(21):2156-64.

​With VCD, time of bed rest is significantly reduced compared to manual compression.3

This provides more comfort to your patients as well as the satisfaction to return home earlier.4

3Schulz-Schüpke S et al. JAMA. 2014 Nov 19;312(19):1981-7.

4Duffin DC et al. J Invasive Cardiol. 2001;13(5):354-6.

​Angio-Seal™ and FemoSeal™ significantly accelerate ambulation versus manual compression1, resulting in shorter hospital stay and increased room turnaround.5

This is associated with overall cost savings for your hospital.

1Cox T et al. Surg Technol Int. 2015 Nov; 27:32-44.

5Akopian G et al. J of Vascular Surgery. 2006;44(1):115-8.

Setting up a day case IR service: Time to act

Upcoming events

Mauris sed purus volutpat, convallis nibh ac, feugiat lorem. Sed dignissim arcu eulala.

EUROPCR 2024
May 14 - 17 , France
Details
All events

Do you need more info about this product?

Our sales representatives are here for you.

Contact us
Send us a message
I have read and accept Terumo Privacy And Cookies Policy and the Terms Of Use*
I wish to receive information and marketing updates from Terumo.
* mandatory fields

Thank you for contacting us!

We typically respond within 2 business days and will come back to you as soon as possible.

Are you a healthcare professional?

This webpage can include promotional content regarding one or several products of Terumo Europe, or some procedures concerning the use or implantation of such products. This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public


For Pharmaceutical Professionals interested in our B2B products portfolio, please visit Terumo Pharmaceutical Solutions.